Fernanda Palhano-Fontes
Research Engineer at the Brain Institute, UFRN
Data updated
Research Footprint
Fernanda Palhano-Fontes appears in 24 tracked papers (2015–2026), most studied alongside Ayahuasca, DMT and LSD, across Healthy Volunteers, Depressive Disorders and Treatment-Resistant Depression (TRD).
Most-cited paper: Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial (814 citations).
Frequent co-authors: Draulio Araújo, Isabel Wießner and Lukas Wießner.
Publication Landscape
How the 24 papers Blossom tracks for Fernanda Palhano-Fontes line up by year, topic, and journal. These are the psychedelic-relevant papers in Blossom's records as of July 2026, not a complete bibliography.
How has Fernanda Palhano-Fontes's publishing grown?
SourcedTracked papers by publication year. Click a year for the running total.
Don't read as total output: only the 24 of 24 tracked papers with a recorded publication date are counted, and these are the psychedelic-relevant papers Blossom tracks, not a complete bibliography. The current year is still filling in.
What does Fernanda Palhano-Fontes publish on?
SourcedTracked papers per topic. Orange marks the largest research focus.
Don't read shares as adding to 100%: a paper tagged with several topics counts once per topic. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Where does Fernanda Palhano-Fontes publish?
SourcedTracked papers per journal. Orange marks the most-used journal.
Counts the journal recorded on each tracked paper; preprints and papers with no journal on file are not shown. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Background & Research
Fernanda Palhano-Fontes is a Brazilian neuroscientist and engineer whose pioneering research has validated the therapeutic potential of ayahuasca. Using fMRI and EEG, her work at the Federal University of Rio Grande do Norte (UFRN) has demonstrated the rapid antidepressant effects of the brew in controlled clinical settings, establishing her as a leading figure in South American psychedelic science.
Key Impact
Led the world's first double-blind, placebo-controlled trial of ayahuasca for treatment-resistant depression.
Collaboration Network
45 collaborators· click a node to visit their profile
Full network →Collaboration Network
See Fernanda Palhano-Fontes's full collaboration network, shared papers, and research connections.
Compounds
Topics
Top Collaborators
Top Collaborators
Unlock clinical summaries, full texts, and related trial mapping.
Affiliations
Institutions, companies, and organisations Fernanda Palhano-Fontes is associated with.
Instituto do Cérebro, Universidade Federal do Rio Grande do Norte
The Instituto do Cérebro (Brain Institute, ICe) is an academic research institute of the Federal University of Rio Grande do Norte (UFRN) in Natal, Brazil, focused on neuroscience research, education and public outreach. It hosts the postgraduate Program in Neurosciences (PGNeuro) and supports related research groups and events.
View stakeholder →Federal University of Rio Grande do Norte (UFRN)
Federal University of Rio Grande do Norte is a public research university in Brazil with active neuroscience and mental health research programmes, including work linked to psychedelic science through affiliated institutes.
View stakeholder →